Xeomin is an injectable neurotoxin made by Merz Pharmaceuticals. Like Botox, Dysport, Jeuveau, and Daxxify, Xeomin uses botulinum toxin type A to temporarily relax facial muscles, reducing the appearance of wrinkles. It is FDA-approved for treating moderate to severe frown lines (glabellar lines) between the eyebrows. Xeomin is also used for certain medical conditions, such as cervical dystonia and blepharospasm (abnormal eye muscle spasms).
Benefits of Xeomin
- “Naked” Neurotoxin Formula: Xeomin is unique in that it is a “naked” form of botulinum toxin, meaning it does not contain accessory proteins or additives. This purified formulation may reduce the likelihood of developing resistance to the treatment over time, which can be beneficial for long-term users of neurotoxins.
- Effective Wrinkle Reduction: Xeomin smooths moderate to severe glabellar lines, helping create a more youthful and relaxed facial appearance.
- Gradual Onset of Results: Patients typically start to see results within 3 to 4 days after treatment, with full effects appearing within 1 to 2 weeks. The subtle, gradual onset can lead to a more natural look.
- Long-Lasting Effects: The effects of Xeomin usually last between 3 to 4 months, similar to other botulinum toxin treatments. This allows for a consistent look without frequent treatments.
- Minimal Downtime: Xeomin is a non-surgical treatment that requires little to no downtime. Patients can usually resume normal activities immediately after treatment.
- Reduced Risk of Immunity: Since Xeomin does not contain additional proteins, the risk of developing antibodies against the treatment may be lower, which can reduce the chance of reduced effectiveness over time.
- Medical Applications: Besides cosmetic benefits, Xeomin is also used therapeutically for conditions like cervical dystonia, blepharospasm, and upper limb spasticity, providing relief from muscle-related symptoms.
How Xeomin Differs from Other Neurotoxins
The “naked” formulation is Xeomin’s defining feature. Without additional complex proteins, it may be less likely to trigger an immune response, which can sometimes lead to decreased efficacy in other neurotoxins. This makes it a preferred choice for individuals who have used neurotoxins regularly or those concerned about resistance.
